Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Publication added under Publications: Lancet Oncology 2024 article on pathological response following neoadjuvant immune checkpoint inhibitors in hepatocellular carcinoma (HCC).
    Difference
    0.1%
    Check dated 2026-03-28T03:19:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition term and a Genetics and Rare Diseases Information Center resource. The site footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-21T00:49:12.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:49:53.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The only visible change is the page revision label updated from Revision: v3.4.1 to Revision: v3.4.2, with no observed changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:43:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Publications section updated: added a new long-term efficacy and biomarker exploration paper (J Hepatol. 2026) and revised the citation to v3.4.1; removed the 2025 online-ahead-of-print reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T22:32:40.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Only the revision labels changed: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. No study content, eligibility criteria, or results information was modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:30:59.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.